FDA adds NAION warning to all GLP-1 drugs; optic neuritis often heralds CNS inflammatory disease

A phoropter hanging from a short arm, its wide housing set with rows of small blank dials around two round lens openings.

The Food and Drug Administration (FDA) required all GLP-1 receptor agonist labels to warn of non-arteritic anterior ischemic optic neuropathy (NAION) and told clinicians to refer suspected cases promptly to an ophthalmologist. A 601-patient multicenter cohort found that first-episode optic neuritis was often the start of broader central nervous system inflammatory disease.

  • FDA Nov 9, 2026
    The Food and Drug Administration (FDA) said on Nov. 9 that it is requiring all GLP-1 receptor agonist (GLP-1 RA) labels to add the risk of non-arteritic anterior ischemic optic neuropathy (NAION) to Warnings and Precautions. A meta-analysis of 126 randomized trials found 6.4 cases per 100,000 person-years with GLP-1 RAs versus 3.8 with placebo or other glucose-lowering drugs. In an FDA Sentinel cohort, risk was higher than with DPP-4 inhibitors (hazard ratio 1.43, 95% CI 1.02 to 2.01) but not significantly higher than with SGLT-2 inhibitors. The FDA told clinicians to refer suspected NAION promptly to an ophthalmologist.
    Sources: FDA, NeurologyLive
  • Research Nov 12, 2026
    A multicenter retrospective cohort study published online in Ophthalmology on Nov. 12 followed 601 consecutive patients with first-episode optic neuritis for a median of two years. Overall, 166 (27.6%) had at least one central nervous system inflammatory event beyond the initial optic neuritis, most often recurrent optic neuritis (58.8%), followed by encephalitis (22.9%) and myelitis (18.3%). At last follow-up, 222 patients (36.9%) had single isolated optic neuritis, 134 (22.3%) myelin oligodendrocyte glycoprotein antibody-associated disease, 125 (20.8%) neuromyelitis optica spectrum disorder and 77 (12.8%) multiple sclerosis.

The weekly innovation roundup for ophthalmology, published every Sunday for the week before; every item links to its sources. Latest ophthalmology news · All specialties

Latest news

Tagged ophthalmology, from the daily briefing

  1. Electronic record alerts fail to cut routine testing before cataract surgery in a UCLA randomized trial
  2. Trabeculotomy is noninferior to combined surgery for primary congenital glaucoma at 3 years

See all the latest news